Ne

Neuro-Oncology

Neuro-Oncology is a medical oncology and neurology journal published on behalf of the Society for Neuro-Oncology. It reports a 2024 Impact Factor of 13.4 and a 2024 CiteScore of 30.2, and offers publication under either a standard licence or an open access licence.

Looking to publish in Neuro-Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Clinical Neurology, Oncology
Impact Factor 13.4
Quartile Q1
Open Access Type Hybrid
ISSN 1522-8517
eISSN 1523-5866
Invitation Only No
Cost Range Standard licence has no licence charge. Open access publication requires an APC. Flat publication fee for certain non-open access article types: $800 for EANO, SNO, or ASNO society members and $1000 for non-society members. Colour charges are USD 600 per colour figure.

Submission Instructions

Neuro-Oncology accepts the following article types. Click on an article type to view submission instructions.

Reviews

Cover Letter A cover letter addressed to the editor must be uploaded as a separate file. The cover letter must confirm that all co-authors have read and approved submission and agree to pay for full color reproduction if color figures are submitted.
Abstract An abstract is required. The abstract must be unstructured and no more than 200 words. The abstract must be unstructured. No mandatory abstract headings are specified.
Manuscript The text body must not exceed 6000 words, excluding references, figure legends, and tables. Text sections must be arranged as Title page, Abstract and keywords, Key Points, Importance of the Study, Text, Required statements, Acknowledgements, References, and Captions for all illustrations. Up to 5 keywords and 2 to 3 brief key points with a total maximum of 260 characters/spaces must be included, and any AI use must be disclosed in the Methods or Acknowledgements section.
References No more than 100 references may be included. References must be numbered in order of citation and cited in the text with superscript Arabic numerals, and for works with more than six authors the first three authors must be followed by "et al.".
Figures & Tables No more than 7 display items may be included. For first submission, display items must be placed at the end of the text after the reference list and figure legends, and tables should otherwise be uploaded as separate files. Tables must be numbered with Arabic numerals and each table must be limited to a maximum length of 2 pages.
Reformat to Neuro-Oncology using Livewrite Premium

Basic And Translational Investigations

Cover Letter A cover letter addressed to the editor is required as a separate file. The cover letter must confirm that all co-authors have read and approved submission and, if color figures are included, agreement to pay for full color reproduction.
Abstract An abstract is required. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Background, Methods, Results, and Conclusions.
Manuscript The text body from Introduction through Discussion must not exceed 5000 words, excluding references, figure legends, and tables. The manuscript must include Title page, Abstract and keywords, Key Points, Importance of the Study, Text, Required statements, Acknowledgements, References, and figure captions, with five required statements included after the Discussion. Up to five keywords, 2 to 3 brief key points with a maximum total of 260 characters and spaces, an Importance of the Study summary of no more than 150 words, and any AI-use disclosure in the Methods or Acknowledgements section must be included.
References No more than 50 references should be included. References must be numbered in order of citation and cited in the text with superscript Arabic numbers, and works with more than six authors must list the first three followed by "et al.".
Figures & Tables No more than 6 display items may be included. For the first submission, display items must be placed at the end of the text after the reference list and figure legends, although tables must otherwise be uploaded as separate files except for the first author-friendly submission. Figure captions are required for all figures.
Reformat to Neuro-Oncology using Livewrite Premium

Clinical Investigations

Cover Letter A cover letter addressed to the editor must be uploaded as a separate file. The cover letter must state that all authors have read, seen, and approved the submitted version of the manuscript and agree to pay for full color reproduction if color figures are submitted.
Abstract An abstract is required. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Background, Methods, Results, and Conclusions.
Manuscript The text body from Introduction through Discussion must not exceed 5000 words, excluding references, figure legends, and tables. The manuscript must include Introduction, Materials and Methods, Results, and Discussion sections, followed after the Discussion by five required statements. The manuscript must include up to five keywords, 2 to 3 brief key points with a maximum total of 260 characters or spaces, an Importance of the Study summary of no more than 150 words, and disclosure of any AI use in the Methods or Acknowledgements section.
References No more than 50 references should be included. References must be numbered in order of citation in the text and cited using superscript Arabic numerals, with more than six authors shortened to the first three followed by "et al.".
Figures & Tables No more than 6 display items may be included. Display items must be placed at the end of the text after the reference list and figure legends for the first submission, and tables should otherwise be uploaded as separate files. Figure captions are required for all figures and must be typed double-spaced after the list of references.
Reformat to Neuro-Oncology using Livewrite Premium

Meta-Analyses

Cover Letter A cover letter addressed to the editor must be uploaded as a separate file. The cover letter must confirm that all co-authors have read and approved the submission and, if color figures are included, agree to pay for full color reproduction.
Abstract A structured abstract is required. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Background, Methods, Results, and Conclusions.
Manuscript The text body from Introduction through Discussion must not exceed 5000 words, excluding references, figure legends, and tables. The manuscript must be arranged in the order Title page, Abstract and keywords, Key Points, Importance of the Study, Text, Required statements, Acknowledgements, References, and Captions for all illustrations, and must include an Importance of the Study section of no more than 150 words. Up to five keywords, 2 to 3 brief key points with a total maximum of 260 characters and spaces, required statements, and disclosure of any AI use in the Methods or Acknowledgements section must be included.
References No more than 100 references may be included. References must be numbered in order of citation in the text and cited using superscript Arabic numerals, and entries with more than six authors must list the first three followed by "et al.".
Figures & Tables No more than 7 tables and/or figures may be included. For the first submission, display items must be placed at the end of the manuscript after the reference list and figure legends, although the entire manuscript including tables and figures may be uploaded in a single Word file. Tables must be uploaded as separate files except for the first author-friendly submission.
Reformat to Neuro-Oncology using Livewrite Premium

Systematic Reviews

Cover Letter A cover letter addressed to the editor must be uploaded as a separate file. The cover letter must state that all co-authors have read, seen, and approved submission of the manuscript and must indicate agreement to pay for full color reproduction if color figures are submitted.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured. Abstract headings must be Background, Methods, Results, and Conclusions.
Manuscript The text body from Introduction through Discussion must not exceed 5000 words, excluding references, figure legends, and tables. Manuscript text sections must be arranged as Title page, Abstract and keywords, Key Points, Importance of the Study, Text, Required statements, Acknowledgements, References, and Captions for all illustrations, and an Importance of the Study section of no more than 150 words must be included. Up to five keywords and 2 to 3 brief key points with a total maximum of 260 characters/spaces must be included, and any use of AI in content generation or preparation must be disclosed in the Methods or Acknowledgements section with each instance and tool detailed.
References No more than 100 references may be included. References must be numbered in order of citation, cited in the text with superscript Arabic numbers, and for works with more than six authors the first three authors must be followed by "et al.".
Figures & Tables No more than 7 tables and/or figures may be included. For the first submission, display items must be placed at the end of the text after the reference list and figure legends, although the entire manuscript including tables and figures may be uploaded in a single Word file. Tables must be numbered with Arabic numerals and each table must have a maximum length of 2 pages, while multi-panel figures should not exceed 8 panels.
Reformat to Neuro-Oncology using Livewrite Premium

Letters To The Editor

Cover Letter A cover letter addressed to the editor must be uploaded as a separate file. The cover letter must state whether all co-authors have read and approved the submission and whether all authors have seen and approved the submitted version of the manuscript.
Abstract Abstract requirements are not specified.
Manuscript The text must not exceed 600 words. Letters to the Editor must address a recent publication in Neuro-Oncology within the prior 3 months or a current topic in the field. Any use of AI in content generation or preparation must be disclosed in the Methods or Acknowledgements section of the manuscript, with each instance and tool clearly detailed.
References No more than 6 references may be included. References must be presented as a numbered list in order of citation in the text, with superscript Arabic numbers used for in-text citation and more than six authors shortened to the first three followed by "et al.".
Figures & Tables No more than 1 simple table or figure with 1 or 2 panels may be included. Display items must be placed at the end of the text after the reference list and figure legends for the first submission, and supplementary data are not permitted.
Reformat to Neuro-Oncology using Livewrite Premium

Guidelines

Cover Letter A cover letter addressed to the editor must be uploaded as a separate file. The cover letter must confirm that all co-authors have read and approved the submission and the submitted version of the manuscript.
Abstract An abstract is required as part of the manuscript.
Manuscript Text sections must be ordered as Title page, Abstract and keywords, Key Points, Importance of the Study, Text, Required statements, Acknowledgements, References, and Captions for all illustrations. The manuscript must include up to five keywords, two to three bulleted key points, required statements, and disclosure of any AI use in the Methods or Acknowledgements section with each instance and tool clearly detailed.
References References must be numbered in order of citation, cited in the text with superscript Arabic numerals, and list the first three authors followed by "et al." when there are more than six authors.
Figures & Tables Multi-panel figures should not exceed 8 panels, and each table must have a maximum length of 2 pages. For the first submission, display items must be placed at the end of the text after the reference list and figure legends, while tables should otherwise be uploaded as separate files. Tables must be numbered with Arabic numerals and include a short descriptive title.
Reformat to Neuro-Oncology using Livewrite Premium

Recent Publications

The prognostic value of CDKN2A/CDKN2B hemizygous deletion in meningioma remains uncertain

Junpeng Ma, Wei Chen, Yaqiang Hong, Dake Zhang, Liang Wang

10.1093/neuonc/noag158
View Publication

A PTX3/TLR4 axis sustains SHH-Medulloblastoma growth and defines a new therapeutic vulnerability

Serena Filiberti, Camilla Tavani, Elena Somenza, Nicolas Tassone, Davide Capoferri, Chiara Romani, Arianna Giacomini, Elisabetta Grillo, Marco Ritelli, Tiziana Annese, Antonio d’Amati, Martina Canton, Elena Mariotto, Roberta Bortolozzi, Giampietro Viola, Andrei Turtoi, Pietro Luigi Poliani, Marta Turati, Roberto Ronca

10.1093/neuonc/noag167
View Publication

Programmable microfluidic modeling of the glioblastoma immune microenvironment recapitulates temporally regulated tumor–immune signaling

Seokgyu Han, Yona Kim, Sein Kim, Chanyang Lee, Jaehyun Lee, Min-Hyeok Kim, Hyo Eun Moon, Sarnai Amartumur, Chaejeong Heo, Sun Ha Paek, Sungsu Park

10.1093/neuonc/noag151
View Publication

The CoREST complex inhibitor, corin, decreases tumor growth, increases cellular differentiation and extends lifespan in ATRT xenograft models

Anupa Geethadevi, Nikhil Vaidya, Robert J Fisher, Tyler R Findlay, Yiming Deng, Khoa Pham, Vikas Kumar, Samuel Beck, Jun Choe, Shiyu Liu, Calixto-Hope G Lucas, Charles G Eberhart, Jinchong Xu, Philip A Cole, Jeffrey Rubens, Marianne Collard, Eric H Raabe, Rhoda M Alani

10.1093/neuonc/noag160
View Publication

Carboplatin induces optic nerve oligodendrocyte loss and impairs myelin sheath microstructure in a mouse model of neurofibromatosis type 1 (NF1)

Benjamin E Aghoghovwia, Kechen Ban, Dimitrios Stavropoulos, Chi-Yu Chen, Bo Wei, Ava S Hamblett, Samer Sharafaldin, Hana El-Toukhy, Momo Harris, Chhay Hok, Varsha K Chandramouli, Carlos Manuel Martínez Cerda, Renae E Bertrand, Sama Alnassiry, Philip L Lorenzi, David H Gutmann, Kun-Che Chang, Rajasekaran Mahalingam, Yuan Pan

10.1093/neuonc/noag163
View Publication

Frequently asked questions

How long does it take to publish?

Papers are normally reviewed within 3-4 weeks of submission. Appeals must be submitted within 4 weeks of the decision. Authors have 3 weeks to accept or decline a transfer offer to a sister journal. Page proof corrections must be returned within 2 working days. Advance Access articles are published online soon after acceptance.

Reformat to Neuro-Oncology using Livewrite Premium

Is a cover letter required?

A cover letter addressed to the editor is required as a separate Word file. It should declare whether the manuscript or any part of it has been previously published or submitted elsewhere, whether all co-authors have read and approved the submission, and agreement to pay approximately $600 per color figure if color figures are submitted. A new cover letter is required for revised manuscripts.

Reformat to Neuro-Oncology using Livewrite Premium

What are the publication costs?

The journal operates a hybrid model. Standard licence publication has no licence charge, open access publication requires an APC, and certain non-open access article types incur a flat publication fee of $800 for EANO, SNO, or ASNO society members or $1000 for non-society members.

Reformat to Neuro-Oncology using Livewrite Premium

Research Topics

Glioma Diagnosis and Treatment Brain Metastases and Treatment Radiomics and Machine Learning in Medical Imaging Cancer, Hypoxia, and Metabolism Meningioma and schwannoma management Neuroblastoma Research and Treatments Cancer Research and Treatments Cancer Genomics and Diagnostics CAR-T cell therapy research Neurofibromatosis and Schwannoma Cases Cancer Immunotherapy and Biomarkers Cancer Treatment and Pharmacology Ferroptosis and cancer prognosis Immune cells in cancer Epigenetics and DNA Methylation Radiopharmaceutical Chemistry and Applications Nanoplatforms for cancer theranostics Immunotherapy and Immune Responses Medical Imaging Techniques and Applications Chromatin Remodeling and Cancer Protein Degradation and Inhibitors MRI in cancer diagnosis Cancer-related cognitive impairment studies Histone Deacetylase Inhibitors Research MicroRNA in disease regulation

Related Journals

CC
Clinical Cancer Research American Association for Cancer Research
Br
Brain Oxford University Press
JO
JCO Oncology Practice LIPPINCOTT WILLIAMS & WILKINS
IA
Infectious Agents and Cancer BioMed Central
OR
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics Cognizant Communication Corporation
NO
Neurobiology of Pain Elsevier BV